Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation Publication Quantitative Model-Informed Dose Selection for a Milvexian Phase III Study in Patients With Atrial Fibrillation This study demonstrates how model-informed approaches can improve dose selection decisions when direct clinical comparisons…CertaraNovember 5, 2025
Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights On-Demand Webinar Delivering on Deadline: Navigating Regulatory Submissions with Pharmacometrics Insights Watch this on-demand webinar to learn how pharmacometrics supports NDA, BLA, and global regulatory submissions.…CertaraNovember 3, 2025
Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Publication Establishing Immune Correlates of Protection Against Respiratory Syncytial Virus Infection to Accelerate Vaccine Development: A Model-Based Meta-Analysis Bridge across studies with Model-based Meta Analysis, incorporating broader data & synthetic patients to enhance…CertaraOctober 31, 2025
At Certara, we’re proud to support WBUR, Boston’s NPR. Blog At Certara, we’re proud to support WBUR, Boston’s NPR. Certara supports public radio because NPR is aligned with our values and helps us spread…CertaraOctober 29, 2025
Key Lessons & Opportunities in applying NCA and PopPK to ADCs Blog Key Lessons & Opportunities in applying NCA and PopPK to ADCs Applying NCA and PopPK to ADCs helps decode complex PK, balance DAR effects, and guide…CertaraOctober 24, 2025
AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success On-Demand Webinar AAPS Webinar – Pediatric Drug Development: Why It’s Critical to Submission Strategy and How Modeling, Regulatory, and Clinical Insights Shape Success Learn how model-informed drug development, clinical pharmacology, and regulatory strategy support successful pediatric drug development…CertaraOctober 21, 2025
Certara Scientists are Among the Topmost Cited Biopharma Researchers Press Release Certara Scientists are Among the Topmost Cited Biopharma Researchers Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…CertaraOctober 20, 2025
Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results Publication Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…CertaraOctober 15, 2025
RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging On-Demand Webinar RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging Access our on-demand webinar and explore proven strategies to develop consistent, high-impact regulatory submission messages.CertaraOctober 9, 2025